Animas Corporation Market Share Analysis

Introduction

GlobalData’s medical devices report, “Animas Corporation Market Share Analysis” provides in-depth information on Animas’s market position in the global insulin delivery devices market category. The report also provides data and information on the overall competitive landscape in the global insulin delivery devices market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global Company shares (in Revenues) information for the in the insulin delivery devices market. Other Key players covered include Eli Lilly, Novo Nordisk, Sanofi-Aventis, Medtronic, Becton,
Dickinson and Company, and F. Hoffmann-La Roche Ltd.
- Animas’s company shares (in Revenues) information in the global insulin delivery devices market.
- All the key data-points are for 2009 and cover all the key regions – North America, Europe, Asia Pacific (APAC), South Central America (SCA), and Middle East and Africa (MEA).
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any – Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.

Highlights

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Animas operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Animas’s market positions.

Report Highlights
Abbott Laboratories
ARKRAY, Inc.
Bayer HealthCare AG
Becton, Dickinson and Company
BioMeridian Corporation
Cytel Incorporated
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Greatbatch, Inc.
LifeScan, Inc.
Medtronic MiniMed, Inc.
Medtronic, Inc.
NetRegulus, Inc.
Novo Nordisk A/S
PolyMedica Corporation
Sanofi-Aventis
Syntermed, Inc.
[Fade out the market survey infos]

TABLE OF CONTENTS

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
3 Definitions of Markets/Categories Covered 8
3.1 Diabetes Care Devices 8
3.1.1 Insulin Delivery 8
4 Company Snapshot 9
4.1 Key Information 9
4.2 Company Overview 9
4.3 Major Products and Services 10
4.3.1 Overview 10
5 Competitors 11
6 Competitive Landscape 12
6.1 Diabetes Care Devices, Insulin Delivery, Global, Company Share (%), 2009 12
7 Animas Corporation Medical Equipment Market Share Analysis 14
7.1 Animas Corporation, Diabetes Care Devices, Global, Market Share (2009) 14
7.2 Animas Corporation, Asia-Pacific, Market Share (2009) 15
7.3 Animas Corporation, Europe, Market Share (2009) 16
7.4 Animas Corporation, Middle East and Africa, Market Share (2009) 18
7.5 Animas Corporation, North America, Market Share (2009) 19
7.6 Animas Corporation, South and Central America, Market Share (2009) 20
8 Key Employees 21
9 Locations And Subsidiaries 21
9.1 Head Office 21
9.2 Other Locations & Subsidiaries 21
10 Financial Deals Landscape 23
10.1 Animas Corporation, Deals Volume Summary, 2005 to YTD 2010 23
11 Animas Corporation Detailed Deal Summary 25
11.1 Asset Purchase 25
11.1.1 Animas and Animas Technologies Acquire Assets of Cygnus 25
11.2 Partnerships 27
11.2.1 Animas Signs Licensing Agreement With Debiotech 27
11.2.2 DexCom Amends Agreement with Animas 28
11.2.3 DexCom Enters Into a Joint Venture with Animas 29
11.3 Acquisition 30
11.3.1 Johnson & Johnson Acquires Animas 30
12 Appendix 31
12.1 Research Methodology 32
12.2 Secondary Research 33
12.3 Primary Research 33
12.4 Models 34
12.5 Forecasts 34
12.6 Expert Panels 34
12.7 GlobalData Consulting 34
12.8 Currency Conversion 35
12.9 Contact Us 36
12.10 Disclaimer 36
[Fade out table of contents]

LIST OF TABLES

1.1 List of Tables
Table 1: Animas Corporation, Key Information, 2009 9
Table 2: Diabetes Care Devices, Insulin Delivery, Company Share by Revenue ($m), 2009 13
Table 3: Animas Corporation, Diabetes Care Devices, Insulin Delivery, Global, Revenue ($m) and Market Share (%), 2009 14
Table 4: Animas Corporation, Diabetes Care Devices, Insulin Delivery, Asia-Pacific, Revenue ($m) and Market Share (%), 2009 15
Table 5: Animas Corporation, Diabetes Care Devices, Insulin Delivery, Europe, Revenue ($m) and Market Share (%), 2009 17
Table 6: Animas Corporation, Diabetes Care Devices, Insulin Delivery, Middle East and Africa, Revenue ($m) and Market Share (%), 2009 18
Table 7: Animas Corporation, Diabetes Care Devices, Insulin Delivery, North America, Revenue ($m) and Market Share (%), 2009 19
Table 8: Animas Corporation, Diabetes Care Devices, Insulin Delivery, South and Central America, Revenue ($m) and Market Share (%), 2009 20
Table 9: Animas Corporation, Key Employees 21
Table 10: Animas Corporation, Other Locations 21
Table 11: Animas Corporation, Deals Volume Summary, 2005 to YTD 2010 23
Table 12: Animas Corporation, Deals Summary, 2005 to YTD 2010 24
Table 13: Animas And Animas Technologies Acquire Assets of Cygnus 25
Table 14: Animas Signs Licensing Agreement With Debiotech 27
Table 15: DexCom Amends Agreement With Animas 28
Table 16: DexCom Enters Into A Joint Venture With Animas 29
Table 17: Johnson & Johnson Acquires Animas 30
Table 18: USD to Local Currency, Average Exchange Rate 2009 35
LIST OF FIGURES

1.2 List of Figures
Figure 1: Diabetes Care Devices, Insulin Delivery, Global, Company Share (%), 2009 12
Figure 2: Animas Corporation, Diabetes Care Devices, Insulin Delivery, Global, Market Share (%), 2009 14
Figure 3: Animas Corporation, Diabetes Care Devices, Insulin Delivery, Asia-Pacific, Market Share (%), 2009 15
Figure 4: Animas Corporation, Diabetes Care Devices, Insulin Delivery, Europe, Market Share (%), 2009 16
Figure 5: Animas Corporation, Diabetes Care Devices, Insulin Delivery, Middle East and Africa, Market Share (%), 2009 18
Figure 6: Animas Corporation, Diabetes Care Devices, Insulin Delivery, North America, Market Share (%), 2009 19
Figure 7: Animas Corporation, Diabetes Care Devices, Insulin Delivery, South and Central America, Market Share (%), 2009 20
Figure 8: Animas Corporation, Deals Volume Summary, 2005 to YTD 2010 23
Figure 9: GlobalData Methodology 32
[Fade out list of tables / figures]